Even grants such as Kerr's that use stem-cell lines that were eligible for funding during the George W. Bush administration are not exempt: the Department of Justice read the injunction to apply to them too, Collins said.
For Kerr, there is little but bad news in Collins's message. In the short term, it means she can unfreeze her cells -the government's interpretation of the injunction allows researchers to spend any grant money already in hand. For Kerr, that amounts to about $100,000 left of an existing two-year award for work aiming to identify factors that regulate pluripotency in embryonic stem cells. Once that money runs out next year, however, the ruling will prevent her from applying for more. And it could get worse: On 30 August, scientists working at the NIH campus in Bethesda, Maryland, were told to immediately shut down all experiments involving human embryonic stem cells. Uncertainty around the correct legal interpretation of the injunction means that 2010 money already in the hands of 199 grantees may still be in jeopardy.
"Even if the injunction is reversed in a couple of weeks, the impact will be in months and years, " because of the disruption to NIH review cycles, says Linzhao Cheng, like Kerr, a stemcell scientist at the Institute for Cell Engineering at Johns Hopkins. Cheng estimates that 40% of his lab's funding, provided by two NIH grants, has been stopped by the injunction.
Still, he counts himself lucky, because he has generous support from the state of Maryland to fall back on -and because just one week before the injunction he received the second year's worth of monies for an NIH grant. For US district-court ruling suspends federal funding for research involving human embryonic stem cells. Kerr, an assistant professor striving to win tenure, the situation is much less certain. Although she gets modest Maryland state funding, it is not at all clear how she will be able to keep operating if she cannot apply for NIH grants. Last June, she submitted three proposals for projects, including one that would have used neural support cells derived from embryonic stem cells to attempt to treat spinal-cord injury in rats. All three are among the projects pulled from peer review. And with the injunction preventing her from applying for further funding on her current work, Kerr's plans are in limbo. A protégé of John Gearhart, one of the first scientists to isolate the cells, Kerr has spent the past seven years building expertise in human embryonic stem cells. To try to switch specialities and begin competing with much more experienced investigators in other areas would be "a real crusher", she says.
Stem
Well established researchers are feeling just as bleak. "It's like making a sculpture and then seeing it destroyed in front of you, " says Ali Brivanlou, who works with stem cells at the Rockefeller University in New York.
Cheng worries most about persuading younger scientists to join a field beset with political uncertainties. "Why take the risk to work on embryonic stem cells that may not be fundable?" he asks.
The sense of shock seemed almost universal among US scientists last week. "This ruling does greater harm to human embryonic-stemcell researchers than any policy ever enacted, " says Sean Morrison, director of the Center for Stem Cell Biology at the University of Michigan in Ann Arbor.
Collins echoed that assessment when he spoke to reporters after the injunction was issued. "This goes beyond politics, " he said, pointing out that stem-cell research holds the promise of effective treatments for an array of diseases that urgently need them. "This decision potentially places all of that in jeopardy, " he said. Lamberth found that they are likely to succeed in winning their case, and are facing "irreparable injury" unless government support for human embryonic-stemcell research is suspended.
His assessment of their probable success is based on the 1996 Dickey-Wicker Amendment, named after the congressmen who affixed it to budget legislation for the niH. the amendment prohibits federal funding of research involving the creation or destruction of human embryos. over the years, successive administrations have interpreted the word "research" in the amendment to refer only to those activities in which embryos are created or destroyed. However, Lamberth writes, the word refers "unambiguously" to the entire body of human embryonic-stem-cell research.
this sweeps away any distinction between deriving stem cell lines and working on lines that have already been derived -the current basis for federal funding. As to the question of competition, figures show that adultstem-cell research has not seen a drop in funding since embryonic stem cells began to draw from the niH budget. in fact, funding for both has risen in parallel (see graph).
As Nature went to press, the Department of Justice was preparing to appeal the ruling. But even if successful, an appeal would only restore funding until the case goes to trial.
the surest way to end the battle would be the passage of legislation that would override the Dickey-Wicker amendment and enshrine the funding eligibility of embryonic-stem-cell research. Representative Diana DeGette (Democrat, Colorado), who in march reintroduced such a bill, says she will work to pass it when Congress resumes sitting on 
